Transfusion Medicine, Tata Medical Center , 14 Middle Arterial Road (EW), Rajarhat, New Town, Kolkata 700160 , India.
Transfusion Medicine, Tata Medical Center , Kolkata , India.
Immunohematology. 2021 Mar;37(1):25-32. doi: 10.21307/immunohematology-2021-006.
Determination of accurate anti-A/-B titers is important for treatment selection in ABO-incompatible stem cell and solid-organ transplants. The standard method for ABO antibody titration is the conventional tube test (CTT). Dithiothreitol (DTT) is commonly used to inactivate the IgM antibody component. The aim of this study was to compare six different methods for ABO antibody titration and to observe the effectiveness of DTT on antibody estimation. A total of 90 healthy voluntary blood donors were enrolled in this study, including 30 each for blood groups A, B, and O. Antibody titrations were performed and tested using the CTT-immediate spin (IS), CTT-antihuman globulin (AHG) with and without DTT, column agglutination technology (CAT)-IS, and CAT-AHG with and without DTT methods. Bead-CAT was used, and the positive cutoff value was set to 1+ for each method to determine the endpoint of the titer. The median values of anti-A/-B titers by IS were found to be higher than those values by AHG in CTT and CAT among group B and A individuals, whereas no statistically significant differences were observed in values from group O individuals for IS and AHG anti-A/-B titers, estimated by each method. Although there was positive correlation between the anti-A/-B titer results obtained using the CTT and CAT in all blood groups, testing using AHG showed poor agreement with and without DTT pretreatment (kappa value of 0.11 and 0.20, respectively). Moderate agreement was observed between CTT-IS and CAT-IS (kappa value of 0.46). Median anti-A/-B AHG titers were reduced by the use of DTT in all blood group samples. Significant differences in the interpretability of anti-A/-B titers were observed among different methods. A uniform approach for selecting the method for ABO antibody titration is highly recommended, and DTT pretreatment of plasma to neutralize IgM activity should be considered to obtain precise values of IgG anti-A/-B titers. . Determination of accurate anti-A/-B titers is important for treatment selection in ABO-incompatible stem cell and solid-organ transplants. The standard method for ABO antibody titration is the conventional tube test (CTT). Dithiothreitol (DTT) is commonly used to inactivate the IgM antibody component. The aim of this study was to compare six different methods for ABO antibody titration and to observe the effectiveness of DTT on antibody estimation. A total of 90 healthy voluntary blood donors were enrolled in this study, including 30 each for blood groups A, B, and O. Antibody titrations were performed and tested using the CTT-immediate spin (IS), CTT-antihuman globulin (AHG) with and without DTT, column agglutination technology (CAT)-IS, and CAT-AHG with and without DTT methods. Bead-CAT was used, and the positive cutoff value was set to 1+ for each method to determine the endpoint of the titer. The median values of anti-A/-B titers by IS were found to be higher than those values by AHG in CTT and CAT among group B and A individuals, whereas no statistically significant differences were observed in values from group O individuals for IS and AHG anti-A/-B titers, estimated by each method. Although there was positive correlation between the anti-A/-B titer results obtained using the CTT and CAT in all blood groups, testing using AHG showed poor agreement with and without DTT pretreatment (kappa value of 0.11 and 0.20, respectively). Moderate agreement was observed between CTT-IS and CAT-IS (kappa value of 0.46). Median anti-A/-B AHG titers were reduced by the use of DTT in all blood group samples. Significant differences in the interpretability of anti-A/-B titers were observed among different methods. A uniform approach for selecting the method for ABO antibody titration is highly recommended, and DTT pretreatment of plasma to neutralize IgM activity should be considered to obtain precise values of IgG anti-A/-B titers. .
确定准确的抗 A/-B 效价对于 ABO 不相容干细胞和实体器官移植的治疗选择非常重要。ABO 抗体效价的标准方法是传统试管试验(CTT)。二硫苏糖醇(DTT)通常用于灭活 IgM 抗体成分。本研究旨在比较六种不同的 ABO 抗体效价测定方法,并观察 DTT 对抗体估计的有效性。本研究共纳入 90 名健康自愿献血者,其中 A、B 和 O 血型各 30 名。使用 CTT-即时旋转(IS)、CTT-抗人球蛋白(AHG)加和不加 DTT、柱凝集技术(CAT)-IS 和 CAT-AHG 加和不加 DTT 方法进行抗体滴定和测试。使用珠-CAT,每个方法的阳性截断值设置为 1+,以确定效价的终点。IS 测定的抗 A/-B 效价中位数高于 CTT 和 CAT 中 B 和 A 个体的 AHG 测定值,而 O 血型个体的 IS 和 AHG 抗 A/-B 效价值在每个方法中均无统计学差异。虽然所有血型中 CTT 和 CAT 获得的抗 A/-B 效价结果之间存在正相关,但使用 AHG 进行检测时,预处理和不预处理(kappa 值分别为 0.11 和 0.20)之间的一致性较差。CTT-IS 和 CAT-IS 之间观察到中度一致性(kappa 值为 0.46)。在所有血型样本中,使用 DTT 可降低抗 A/-B AHG 效价的中位数。不同方法之间观察到抗 A/-B 效价的可解释性存在显著差异。强烈建议采用统一的方法选择 ABO 抗体效价测定方法,并且应该考虑使用 DTT 预处理血浆以中和 IgM 活性,从而获得 IgG 抗 A/-B 效价的精确值。 .